Hepatitis Therapeutics Market Size to Reach $19.71 Bn, Globally, by 2030 at 3.1% CAGR

- Increase in product approvals and launches, rise in collaborations between major players in the market, and robust presence of pipeline drugs drive the growth of the global hepatitis therapeutics market.

PORTLAND, Ore., Dec. 1, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Hepatitis Therapeutics Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Drug Class (Oral Antivirals, and Immune Modulators), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021–2030". According to the report, the global hepatitis therapeutics market generated $14.47 billion in 2020, and is anticipated to generate $19.71 billion by 2030, witnessing a CAGR of 3.1% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/14883

Prime determinants of growth

Increase in product approvals and launches, rise in collaborations between major players in the market, and robust presence of pipeline drugs drive the growth of the global hepatitis therapeutics market. However, high cost of hepatitis drugs hinder the market growth. On the other hand, growth opportunities in emerging markets present new opportunities in the coming years.

Covid-19 Scenario

• The outbreak of the COVID-19 pandemic has had a negative impact on the growth of the global hepatitis therapeutics market.
• Patients with hepatitis B have confronted various new difficulties in getting to clinical consideration and treatment because of deferred arrangements and de-prioritization of routine hepatitis.
• Some patients experienced issues when diagnosed with COVID-19 and with liver sickness at the same time.

The hepatitis C segment to maintain its leadership status throughout the forecast period

Based on disease type, the hepatitis C segment held the highest market share in 2020, accounting for nearly three-fifths of the global hepatitis therapeutics market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 3.5% from 2021 to 2030, owing to growing prevalence of hepatitis C globally and due to new drug launches. The report also includes hepatitis B.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/14883

The oral antivirals segment to maintain its lead position during the forecast period

Based on drug class, the oral antivirals segment accounted for the largest share in 2020, contributing to 88% of the global hepatitis therapeutics market, and is projected to maintain its lead position during the forecast period. This is due to increase in demand of novel drugs and approval of new drugs. However, the immune modulators segment is expected to portray the largest CAGR of 4.2% from 2021 to 2030.

North America to maintain its dominance by 2030

Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than two-fifths of the global hepatitis therapeutics market. Moreover, the Asia-Pacific region is expected to witness the fastest CAGR of 4.3% during the forecast period, owing to rise in investments in growth in R&D activities and geographic expansion of hepatitis therapeutics companies in this region.

Leading Market Players

• Abbvie Inc.
• Bristol Myers & Squibb
• Cipla Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc.
• Hoffmann-La Roche Ltd.
• Lupin Ltd.
• Merck & Co. Inc.
• Teva Pharmaceutical Industries Ltd.
• Zydus Cadila.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Cannabis Market in Medical - Global Opportunity Analysis and Industry Forecast, 2020–2028

Minimally Invasive Surgical Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Mass Spectrometry Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Telemedicine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Over The Counter (OTC) Test Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Healthcare CRM Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Hospital-Acquired Infection Control Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Cryotherapy Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Medical Waste Management Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Cosmetic Dentistry Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg